Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: high pre-test probability of HCC, they result in high specificity for diagnosis of this entity
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The differences between these guidelines and nuances in imaging of HCC are discussed in this review article. Lastly, the role of imaging beyond the lesion characterization and upcoming advancements in this field are discussed.
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related death globally.
APA
Haghshomar M, Kierans AS, et al. (2025). Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond.. The British journal of radiology, 98(1173), 1344-1355. https://doi.org/10.1093/bjr/tqaf123
MLA
Haghshomar M, et al.. "Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond.." The British journal of radiology, vol. 98, no. 1173, 2025, pp. 1344-1355.
PMID
40609019 ↗
Abstract 한글 요약
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related death globally. It is unique among other cancers in the sense that imaging-based diagnosis is accepted as a definite diagnosis among at-risk patients by all major guidelines. The classic imaging finding of HCC on multiphasic contrast-enhanced CT and MRI is hyperenhancement during the arterial phase with hypoenhancement ("washout") and enhancing capsule in the portal venous and/or delayed phases. When distinct imaging features of HCC are applied in patients with high pre-test probability of HCC, they result in high specificity for diagnosis of this entity. There are several imaging-based diagnostic algorithms developed by different societies, all aimed at high specificity and reasonable sensitivity for noninvasive diagnosis of HCC in at-risk population. These guidelines differ in their clinical scope, diagnostic algorithm, intended users, complexity level, and technical requirements as well as their clinical and socioeconomic contexts. The differences between these guidelines and nuances in imaging of HCC are discussed in this review article. Lastly, the role of imaging beyond the lesion characterization and upcoming advancements in this field are discussed.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Carcinoma
- Hepatocellular
- Liver Neoplasms
- Algorithms
- Magnetic Resonance Imaging
- Tomography
- X-Ray Computed
- Practice Guidelines as Topic
- Contrast Media
- Liver
- Sensitivity and Specificity
- LI-RADS (Liver Imaging Reporting and Data System)
- carcinoma
- hepatocellular
- hepatocellular carcinoma (HCC)
- imaging-based diagnosis
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.